Gene Transplant Global Market Report 2025

Description

Gene transplant refers to the process of introducing healthy or modified genes into a patient's cells to replace or repair defective genes responsible for disease. Its primary goal is to correct genetic disorders, restore normal cellular function, or provide therapeutic effects, such as enhancing the immune system's ability to target diseases.

The primary types of gene transplant are autologous and allogeneic. Autologous involves collecting a patient's own cells, genetically modifying them, and transplanting them back into the same individual to treat or prevent disease. Applications include genetic disorders, cancer, rare diseases, and more, serving hospitals, research institutions, biotechnology companies, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The gene transplant market research report is one of a series of new reports from The Business Research Company that provides gene transplant market statistics, including the gene transplant industry global market size, regional shares, competitors with the gene transplant market share, detailed gene transplant market segments, market trends, and opportunities, and any further data you may need to thrive in the gene transplant industry. This gene transplant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gene transplant market size has grown rapidly in recent years. It will grow from $3.65 billion in 2024 to $4.13 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be linked to rising success rates in early clinical trials, greater adoption of next-generation sequencing (NGS), increased development of cell-based therapies, and wider availability of orphan drug designations.

The gene transplant market size is expected to see rapid growth in the next few years. It will grow to $6.72 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be linked to heightened focus on one-time curative treatments, expansion of manufacturing capacity for gene therapies, growing regulatory harmonization, increasing applications in neurological disorders, and greater use of synthetic biology platforms. Key trends during the forecast period include integration of artificial intelligence with gene editing platforms, combination of gene therapy with regenerative medicine, use of wearable biosensors in gene therapy trials, application of 3D bioprinting with gene-modified cells, and incorporation of blockchain in clinical data management.

The growth of gene therapy is expected to drive the expansion of the gene transplant market in the coming years. Gene therapy is a technique that alters a person's genes to prevent or treat diseases. This field is growing due to advancements in delivery systems, which allow for the safe, efficient, and targeted transport of genetic material into cells. Gene therapy plays a key role in managing genetic disorders by offering targeted treatments that can correct or replace defective genes, providing solutions for conditions that were once untreatable. By addressing the root cause of diseases, gene therapy helps reduce symptoms and halt disease progression, ultimately improving patient outcomes and quality of life. For example, the American Society of Gene & Cell Therapy (ASGCT) reported in December 2024 that the FDA approved six gene therapy products in 2023, an increase from five approvals in 2022. As a result, the rise in gene therapy is accelerating the growth of the gene transplant market.

Key players in the gene transplant market are focusing on the development of advanced technologies, such as automated cloning platforms, to enhance the efficiency, precision, and speed of gene therapy. Automated cloning platforms are systems that isolate and culture single cells into monoclonal lines, improving the speed, consistency, and accuracy of gene transplant and therapy procedures. For instance, in November 2024, iotaSciences Ltd., a UK-based life sciences technology company, launched the XT Single-Cell Cloning Platform. This platform integrates automated microfluidics, AI-driven image analysis, and nano-dispensing technology, enabling high-throughput and precise isolation of individual cells. Designed to accelerate gene therapy development, it ensures monoclonality-a key regulatory requirement-while reducing processing time from weeks to days. This system also supports CRISPR-based gene editing by efficiently delivering editing components to target cells, thus advancing the development of next-generation therapies.

In January 2025, Roche, a Swiss pharmaceutical company, expanded its capabilities by acquiring Poseida Therapeutics Inc. for $1.5 billion. This acquisition strengthens Roche's gene transplant and cell therapy portfolio by giving it access to Poseida's non-viral gene editing and delivery technologies, which are designed to treat genetic disorders and cancers. Poseida Therapeutics Inc. is a US-based company focused on developing gene transplant therapies.

Major players in the gene transplant market are Bayer AG, Novartis AG, CSL Behring LLC, Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., CRISPR Therapeutics AG, Beam Therapeutics Inc., Rocket Pharmaceuticals Inc., Voyager Therapeutics Inc., Sangamo Therapeutics Inc., Editas Medicine Inc., Krystal Biotech Inc., bluebird bio Inc., Orchard Therapeutics plc, 4D Molecular Therapeutics Inc., Solid Biosciences Inc., uniQure N.V., and MeiraGTx Holdings plc.

North America was the largest region in the gene transplant market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene transplant report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene transplant market includes revenues earned by entities through gene therapy consultation, genetic engineering, cell processing and modification, vector delivery services, clinical trial support, and patient-specific treatment administration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The gene transplant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Autologous; Allogeneic
2) By Application: Genetic Disorders; Cancer; Rare Diseases; Other Application
3) By End-User: Hospitals; Research Institutes; Biotechnology Companies; Other End-Users
Subsegments:
1) By Autologous: Hematopoietic Stem Cell Transplantation; Gene-Modified Autologous Cell Therapy; Chimeric Antigen Receptor T (CAR-T) Cell Therapy
2) By Allogeneic: Hematopoietic Stem Cell Transplantation; Gene-Modified Allogeneic Cell Therapy; Allogeneic Chimeric Antigen Receptor T (CAR-T) Cell Therapy; Off-The-Shelf Gene Therapies
Companies Mentioned: Bayer AG; Novartis AG; CSL Behring LLC; Charles River Laboratories International Inc.; BioMarin Pharmaceutical Inc.; Sarepta Therapeutics Inc.; Ultragenyx Pharmaceutical Inc.; CRISPR Therapeutics AG; Beam Therapeutics Inc.; Rocket Pharmaceuticals Inc.; Voyager Therapeutics Inc.; Sangamo Therapeutics Inc.; Editas Medicine Inc.; Krystal Biotech Inc.; bluebird bio Inc.; Orchard Therapeutics plc; 4D Molecular Therapeutics Inc.; Solid Biosciences Inc.; uniQure N.V.; MeiraGTx Holdings plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r38538

1. Executive Summary

2. Gene Transplant Market Characteristics

3. Gene Transplant Market Trends And Strategies

4. Gene Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Gene Transplant Growth Analysis And Strategic Analysis Framework

5.1. Global Gene Transplant PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Gene Transplant Market Growth Rate Analysis
5.4. Global Gene Transplant Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Gene Transplant Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Gene Transplant Total Addressable Market (TAM)

6. Gene Transplant Market Segmentation

6.1. Global Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous
Allogeneic
6.2. Global Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Disorders
Cancer
Rare Diseases
Other Applications
6.3. Global Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Biotechnology Companies
Other End-Users
6.4. Global Gene Transplant Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Transplantation
Gene-Modified Autologous Cell Therapy
Chimeric Antigen Receptor T (CAR-T) Cell Therapy
6.5. Global Gene Transplant Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hematopoietic Stem Cell Transplantation
Gene-Modified Allogeneic Cell Therapy
Allogeneic Chimeric Antigen Receptor T (CAR-T) Cell Therapy
Off-The-Shelf Gene Therapies

7. Gene Transplant Market Regional And Country Analysis

7.1. Global Gene Transplant Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Gene Transplant Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Transplant Market

8.1. Asia-Pacific Gene Transplant Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Transplant Market

9.1. China Gene Transplant Market Overview
9.2. China Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Transplant Market

10.1. India Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Transplant Market

11.1. Japan Gene Transplant Market Overview
11.2. Japan Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Transplant Market

12.1. Australia Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Transplant Market

13.1. Indonesia Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Transplant Market

14.1. South Korea Gene Transplant Market Overview
14.2. South Korea Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Transplant Market

15.1. Western Europe Gene Transplant Market Overview
15.2. Western Europe Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Transplant Market

16.1. UK Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Transplant Market

17.1. Germany Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Transplant Market

18.1. France Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Transplant Market

19.1. Italy Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Transplant Market

20.1. Spain Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Transplant Market

21.1. Eastern Europe Gene Transplant Market Overview
21.2. Eastern Europe Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Transplant Market

22.1. Russia Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Transplant Market

23.1. North America Gene Transplant Market Overview
23.2. North America Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Transplant Market

24.1. USA Gene Transplant Market Overview
24.2. USA Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Transplant Market

25.1. Canada Gene Transplant Market Overview
25.2. Canada Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Transplant Market

26.1. South America Gene Transplant Market Overview
26.2. South America Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Transplant Market

27.1. Brazil Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Transplant Market

28.1. Middle East Gene Transplant Market Overview
28.2. Middle East Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Transplant Market

29.1. Africa Gene Transplant Market Overview
29.2. Africa Gene Transplant Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Gene Transplant Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Gene Transplant Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Transplant Market Competitive Landscape And Company Profiles

30.1. Gene Transplant Market Competitive Landscape
30.2. Gene Transplant Market Company Profiles
- 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Transplant Market Other Major And Innovative Companies

31.1. Sarepta Therapeutics Inc.
31.2. Ultragenyx Pharmaceutical Inc.
31.3. CRISPR Therapeutics AG
31.4. Beam Therapeutics Inc.
31.5. Rocket Pharmaceuticals Inc.
31.6. Voyager Therapeutics Inc.
31.7. Sangamo Therapeutics Inc.
31.8. Editas Medicine Inc.
31.9. Krystal Biotech Inc.
31.10. bluebird bio Inc.
31.11. Orchard Therapeutics plc
31.12. 4D Molecular Therapeutics Inc.
31.13. Solid Biosciences Inc.
31.14. uniQure N.V.
31.15. MeiraGTx Holdings plc

32. Global Gene Transplant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Transplant Market

34. Recent Developments In The Gene Transplant Market

35. Gene Transplant Market High Potential Countries, Segments and Strategies

35.1 Gene Transplant Market In 2029 - Countries Offering Most New Opportunities
35.2 Gene Transplant Market In 2029 - Segments Offering Most New Opportunities
35.3 Gene Transplant Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer